Translating Clinical Data Into Multidisciplinary Practice for ES-SCLC
Luis Paz-Ares, MD, PhD
Lauren A. Byers, MD
Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC
Transformative Insights: Latest Evidence for B7-H3 ADCs From WCLC and ESMO 2025
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
Global Perspectives on Perioperative Immunotherapy in LA HNSCC
Kevin J Harrington, PhD, FRCP, FRCR, FRSB
Christophe Le Tourneau, MD, PhD
Advanced Therapeutic Strategies and Resistance Mechanisms in CLL
Shankara Paneesha, MD FRCP FRCPath
Innovations in Oncology Learning Center: From Guidelines to Practice: Melanoma
John M. Kirkwood, MD
Paolo A. Ascierto, MD
Hussein Tawbi, MD, PhD
Sapna Patel, MD
Emerging and Practice Changing Data in Immunotherapy Strategies for Melanoma
Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)
Stephen Liu, MD
Joshua K. Sabari, MD
Susan Scott, MD
Reimagining Lung Cancer Treatment: A Journey Through New and Emerging Therapeutics Related to the Care of Patients with Small Cell and Non-Small Cell Lung Cancer
Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage III/IV Melanoma
MET and Other Emerging Targets in Metastatic NSCLC
Emerging Therapeutic Developments in Non-Targetable Metastatic NSCLC
Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC
Applications of Emerging Data in Resectable NSCLC
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.